Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment

[1] Moynihan R(2021)Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review BMJ Open 11 1192-1200

[2] Sanders S(2020)Clinical characteristics and diagnostic challenges of COVID-19: an update from the global perspective Front Public Health 8 281-2090

[3] Michaleff ZA(2020)Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study Lancet Respir Med 8 2082-586

[4] Scott AM(2021)Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs) J Virol Methods 291 573-2080

[5] Clark J(2021)Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients Viruses 13 2074-89

[6] To EJ(2019)A dose-finding study of a wild-type influenza A(H3N2) virus in a healthy volunteer human challenge model Clin Infect Dis 69 84-2069

[7] Israfil SMH(2020)A systematic review of the clinical utility of cycle threshold values in the context of COVID-19 Infect Dis Ther 9 270-605

[8] Sarker MMR(2020)Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease Am J Emerg Med 38 2062-875

[9] Rashid PT(2020)Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19 Int J Infect Dis 98 603-S30

[10] Talukder AA(2020)COVID-19 length of hospital stay: a systematic review and data synthesis BMC Med 18 869-326

[1] Moynihan R(2021)Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review BMJ Open 11 1192-1200

[2] Sanders S(2020)Clinical characteristics and diagnostic challenges of COVID-19: an update from the global perspective Front Public Health 8 281-2090

[3] Michaleff ZA(2020)Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study Lancet Respir Med 8 2082-586

[4] Scott AM(2021)Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs) J Virol Methods 291 573-2080

[5] Clark J(2021)Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients Viruses 13 2074-89

[6] To EJ(2019)A dose-finding study of a wild-type influenza A(H3N2) virus in a healthy volunteer human challenge model Clin Infect Dis 69 84-2069

[7] Israfil SMH(2020)A systematic review of the clinical utility of cycle threshold values in the context of COVID-19 Infect Dis Ther 9 270-605

[8] Sarker MMR(2020)Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease Am J Emerg Med 38 2062-875

[9] Rashid PT(2020)Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19 Int J Infect Dis 98 603-S30

[10] Talukder AA(2020)COVID-19 length of hospital stay: a systematic review and data synthesis BMC Med 18 869-326